Mission Peluches

A cuddly science outreach project

Chris Wylie and Janet Heasman

An interview with Christopher Wylie and Janet Heasman

limbs and genitals



Tissue-specific genome editing in Ciona embryos by CRISPR/Cas9

European Advocate General critical of stem cell patents

Posted by on March 11th, 2011

I expect many of you have already seen reports that the European Advocate General has taken a very restrictive view on patents for technologies that use human embyronic stem cells. This is the next installment in a long-running legal battle over a patent awarded to stem cell scientist Oliver Bruestle in 1999 and challenged by Greenpeace in 2004. Prof Bruestle and others are voicing serious concerns about the Advocate General’s postion (see news story at http://www.eurostemcell.org/story/european-advocate-general-critical-stem-cell-patents for example). Just wondered what Node readers think about all this?
GD Star Rating

Category News | 1 Comment »

  1. M. Varju says:
    The AG`s opinion is revolting. He said he will not consider the ethical, socio-economic, research context of the issue but will give a purely legal definition based on (secondary school biology). He did not distinguish between emrbyo sources (IVF, SCNT) just said everything that falls under the legal definition must be protected.

    Rate comment: Thumb up 0 Thumb down 0

Leave a comment


Copyright 2010 - 2012 The Company of Biologists Ltd

Company of Biologists